Caplin Point Laboratories Ltd

Stage 2 · Advancing · week 16Setup 6.6 ★★ GoodStrong +7.3

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. More about the company

₹2,649.1
-1.14% today
₹20,136 Cr · Large cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-7.6%
₹1,504.8 lo₹2,867.4 hi
7.6% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 16
1w13w26w
Week 16 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
24.6%
200 DMA: ₹2,126.7 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.52x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
MA20 gently rising · +1.7% vs MA50 +2.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-5.8%
3M
+4.8%
6M
+68.8%
YTD
+33.7%
1Y
+31.8%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #38 of 77 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #33 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 37w
S2 34w
S4 24w
S2 16w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 37w → S3 12w → S2 34w → S3 9w → S4 5w → S1 7w → S2 4w → S1 1w → S4 3w → S1 1w → S2 6w → S3 5w → S4 24w → S1 5w → S2 16w current
Total tracked: 168 weeks across 15 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-06-16
4 appearances in last 60 days. First seen: 2024-06-19.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 16 · Vol 0.52x
2026-10-06S2
Wk 16 · Vol 0.56x
2026-10-05S2
Wk 16 · Vol 0.72x
2026-10-01S2
Wk 16 · Vol 0.78x
2026-09-30S2
Wk 16 · Vol 0.79x
2026-09-29S2
Wk 15 · Vol 0.48x
2026-09-28S2
Wk 15 · Vol 0.62x
2026-09-25S2
Wk 15 · Vol 0.93x
2026-09-24S2
Wk 15 · Vol 7.25x
2026-09-23S2
Wk 15 · Vol 0.37x
2026-09-22S2
Wk 14 · Vol 0.69x
2026-09-21S2
Wk 14 · Vol 0.51x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹2,638.5
200 DMA
₹2,126.7
52W High
₹2,867.4
52W Low
₹1,504.8
5D Low
₹2,604
Resistance levels (recent highs)
20d High
₹2,867.4
60d High
₹2,867.4
120d High
₹2,867.4
250d High
₹2,867.4
Next resistance
+8.2%
to 20d High
Ask the Market AI about CAPLIPOINTAsk →
P/E (TTM)
24.1
Forward 18.9
Earnings Growth (YoY)
+19.4%
Revenue +19.0%
ROE
+19.9%
Profit margin +29.3%
Dividend Yield
0.39%
P/B 4.4
About this companyHealth Care· Pharmaceuticals

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.